MEP14608A - Compounds with a sulphonamide group and pharmaceutical compositions containing these compounds - Google Patents

Compounds with a sulphonamide group and pharmaceutical compositions containing these compounds

Info

Publication number
MEP14608A
MEP14608A MEP-146/08A MEP14608A MEP14608A ME P14608 A MEP14608 A ME P14608A ME P14608 A MEP14608 A ME P14608A ME P14608 A MEP14608 A ME P14608A
Authority
ME
Montenegro
Prior art keywords
compounds
group
erythrocytes
substances
pharmaceutical compositions
Prior art date
Application number
MEP-146/08A
Other languages
Bosnian (bs)
English (en)
Inventor
Walter Elger
Alexander Hillisch
Annemarie Hedden
Sigfrid Schwarz
Klaus Schoellkopf
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7644802&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MEP14608(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of MEP14608A publication Critical patent/MEP14608A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0044—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an estrane or gonane skeleton, including 18-substituted derivatives and derivatives where position 17-beta is substituted by a carbon atom not directly bonded to another carbon atom and not being part of an amide group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
MEP-146/08A 2000-05-31 2001-05-08 Compounds with a sulphonamide group and pharmaceutical compositions containing these compounds MEP14608A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10027887A DE10027887A1 (de) 2000-05-31 2000-05-31 Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
PCT/EP2001/005169 WO2001091797A2 (de) 2000-05-31 2001-05-08 Verbindungen mit einer sulfonamidgruppe und diese verbindungen enthaltende pharmazeutische zusammensetzungen

Publications (1)

Publication Number Publication Date
MEP14608A true MEP14608A (en) 2010-06-10

Family

ID=7644802

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-146/08A MEP14608A (en) 2000-05-31 2001-05-08 Compounds with a sulphonamide group and pharmaceutical compositions containing these compounds

Country Status (29)

Country Link
US (2) US7507725B2 (ru)
EP (1) EP1294402B2 (ru)
JP (1) JP2003534386A (ru)
KR (3) KR20030017524A (ru)
CN (1) CN1441678A (ru)
AT (1) ATE315407T1 (ru)
AU (2) AU2001265933B2 (ru)
BG (1) BG107556A (ru)
BR (1) BR0111294A (ru)
CA (1) CA2410630A1 (ru)
CZ (1) CZ2003621A3 (ru)
DE (2) DE10027887A1 (ru)
DK (1) DK1294402T4 (ru)
EA (1) EA006432B1 (ru)
ES (1) ES2256256T5 (ru)
HR (1) HRP20021038B1 (ru)
HU (1) HUP0301949A3 (ru)
IL (2) IL152932A0 (ru)
ME (1) MEP14608A (ru)
MX (1) MXPA02011844A (ru)
NO (1) NO20025739D0 (ru)
NZ (1) NZ535201A (ru)
PL (1) PL206462B1 (ru)
PT (1) PT1294402E (ru)
SK (1) SK2912003A3 (ru)
UA (1) UA76953C2 (ru)
WO (1) WO2001091797A2 (ru)
YU (1) YU90102A (ru)
ZA (1) ZA200209490B (ru)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10027887A1 (de) * 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
US8026229B2 (en) * 2001-08-13 2011-09-27 Sterix Limited Antitumor-active 2-alkoxyestradiol sulfamates
DE102004025986A1 (de) * 2004-05-21 2005-12-15 Schering Ag Steroid-Prodrugs mit androgener Wirkung
US20050277625A1 (en) * 2004-05-21 2005-12-15 Ralf Wyrwa Estriol and estetrol prodrugs
DE102004025966A1 (de) * 2004-05-21 2005-12-15 Schering Ag Estradiol-Prodrugs
US7534780B2 (en) * 2004-05-21 2009-05-19 Bayer Schering Pharma Aktiengesellschaft Estradiol prodrugs
DE102004025985A1 (de) * 2004-05-21 2005-12-15 Schering Ag Estriol- und Estetrol-Prodrugs
US20050282793A1 (en) * 2004-05-21 2005-12-22 Ralf Wyrwa Steroid prodrugs with androgenic action
US20070197488A1 (en) * 2005-11-29 2007-08-23 Olaf Peters Prodrugs of ERbeta-selective substances, process for their production, and pharmaceutical compositions that contain these compounds
US20070123500A1 (en) * 2005-11-29 2007-05-31 Gerd Mueller Prodrugs of ERbeta-selective substances, processes for their preparation and pharmaceutical compositions comprising these compounds
DE102005057225A1 (de) * 2005-11-29 2007-05-31 Bayer Schering Pharma Ag Prodrugs ERß-selektiver Substanzen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE102005057224A1 (de) * 2005-11-29 2007-05-31 Bayer Schering Pharma Ag Prodrugs ERß-selektiver Substanzen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE102005057408A1 (de) * 2005-11-30 2007-05-31 Bayer Schering Pharma Ag Sulfamoylsulfonat-Prodrugs
US20070135399A1 (en) * 2005-11-30 2007-06-14 Ralf Wyrwa Heteroaromatic sulphonamide prodrugs
US20070135375A1 (en) * 2005-11-30 2007-06-14 Ralf Wyrwa Sulfamoyl sulfonate prodrugs
DE102005057421A1 (de) * 2005-11-30 2007-05-31 Bayer Schering Pharma Ag Heteroaromatische Sulfonamid-Prodrugs
EP2285687B1 (en) 2008-05-20 2016-03-16 Grinon Industries Fluid transfer assembly and methods of fluid transfer
US8777182B2 (en) 2008-05-20 2014-07-15 Grinon Industries Fluid transfer assembly and methods of fluid transfer
US9100458B2 (en) * 2008-09-11 2015-08-04 At&T Intellectual Property I, L.P. Apparatus and method for delivering media content
CN101987104A (zh) * 2009-08-05 2011-03-23 天津金耀集团有限公司 一种杂芳香基氨磺酰基羧酸酯碳酸酐酶抑制剂的眼用组合物
CN101987102A (zh) * 2009-08-05 2011-03-23 天津金耀集团有限公司 一种糖皮质激素杂芳香基氨磺酰基羧酸酯的眼用抗炎组合物
RU2612985C2 (ru) * 2011-12-30 2017-03-14 Гринон Индастриз Узел переноса текучей среды и способы переноса текучей среды
EP3019172B1 (en) 2013-07-11 2019-09-25 Evestra, Inc. Pro-drug forming compounds
EP3173113A1 (en) * 2015-11-27 2017-05-31 Sanofi-Aventis Deutschland GmbH An injection needle assembly
JP6924756B2 (ja) 2015-11-27 2021-08-25 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング キャップをもつ薬物送達デバイス
PE20210155A1 (es) 2017-10-19 2021-01-26 Evestra Inc Anticonceptivos de profarmacos de progestina de accion mas prolongada

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1203042B (de) 1963-11-21 1965-10-14 Schering Ag Fungizide Mittel
GB1593609A (en) 1978-01-31 1981-07-22 Christiaens Sa A Pyridine sulfonamides
US4244940A (en) * 1978-09-05 1981-01-13 Bio-Rad Laboratories, Inc. Single-incubation two-site immunoassay
US4513006A (en) 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
GB8327256D0 (en) * 1983-10-12 1983-11-16 Ici Plc Steroid derivatives
US5001234A (en) * 1987-04-16 1991-03-19 The Upjohn Company Cyclic hydrocarbons with an aminoalkyl sidechain
US4792569A (en) 1987-08-27 1988-12-20 Mcneilab, Inc. Anticonvulsant phenethyl sulfamates
US5116828A (en) 1989-10-26 1992-05-26 Nippon Zoki Pharmaceutical Co., Ltd. Pharmaceutical composition for treatment of osteoporosis
US5025031A (en) 1989-11-30 1991-06-18 A. H. Robins Co., Inc. Aryl and aryloxyalkyl sulfamate esters useful as anticonvulsants
GB9118478D0 (en) * 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
DE4236237A1 (de) 1992-10-27 1994-04-28 Behringwerke Ag Prodrugs, ihre Herstellung und Verwendung als Arzneimittel
US5384327A (en) 1992-12-22 1995-01-24 Mcneilab, Inc. Anticonvulsant sorbopyranose sulfamates
IL109431A (en) 1993-05-14 2001-01-11 Warner Lambert Co Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds
DE4429397C2 (de) * 1994-08-09 2003-11-20 Jenapharm Gmbh Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE4429398C2 (de) * 1994-08-09 1997-09-11 Jenapharm Gmbh Verwendung von Estra-1,3,5(10)-trien-Derivaten zur hormonalen Kontrazeption
US5571933A (en) * 1994-11-17 1996-11-05 Duquesne University Of The Holy Ghost Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use
DE19540233B4 (de) 1995-10-19 2005-08-25 Schering Ag Sulfamat-Derivate von 1,3,5(10)-Estratrien-Derivaten, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
US5705495A (en) * 1995-10-19 1998-01-06 Jenapharm Gmbh & Co. Kg. Sulfamate derivatives of 1,3,5(10)-estratriene derivatives, methods for their production and pharmaceuticals containing these compounds
DE19712488A1 (de) * 1997-03-25 1998-10-01 Knoell Hans Forschung Ev Steroidsulfamate, Verfahren zu ihrer Herstellung und Anwendung derselben
DE19723794A1 (de) * 1997-06-06 1998-12-10 Jenapharm Gmbh Nichtestrogene Derivate des Estradiols mit antioxidativer Aktivität
EP1100736A1 (en) * 1998-07-29 2001-05-23 Crisplant A/S Parcel singulation system
US6583130B1 (en) * 1999-09-13 2003-06-24 Schering Ag C13-substituted estra-1,3,5,(10)-trien-3-yl sulfamates, methods of preparing same, and pharmaceutical compositions containing these compounds
US6958327B1 (en) * 1999-11-02 2005-10-25 Schering, Ag 18 Norsteroids as selectively active estrogens
SK10022002A3 (sk) 2000-01-14 2002-12-03 Sterix Limited Farmaceutický prostriedok a jeho použitie
DK1272504T3 (da) 2000-04-12 2007-10-01 Bayer Schering Pharma Ag 8.Beta-hydrocarbylsubstituerede östradiener til anvendelse som selektive östrogener
DE10027887A1 (de) 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
US6355666B1 (en) * 2000-06-23 2002-03-12 Medinox, Inc. Protected forms of pharmacologically active agents and uses therefor
JP2004532838A (ja) * 2001-03-02 2004-10-28 ブリストル−マイヤーズ スクイブ カンパニー メラノコルチン受容体のモデュレーターとして有用な化合物及びそれを含む製薬組成物
WO2002076464A1 (en) * 2001-03-22 2002-10-03 Arena Pharmaceuticals, Inc. Anti-psychosis combination
US6956031B2 (en) * 2002-03-27 2005-10-18 Schering Aktiengesellschaft 11β-Substituted 19-nor-17-α-pregna-1,3,5(10)-trien-17β-ols with a 21,16α-lactone ring
DE10226326A1 (de) 2002-06-11 2004-01-15 Schering Ag 9-alpha-substiuierte Estratriene als selektiv wirksame Estrogene
US7414043B2 (en) * 2002-06-11 2008-08-19 Schering Ag 9-α-substituted estratrienes as selectively active estrogens
PL1689410T3 (pl) 2003-11-26 2008-10-31 Bayer Schering Pharma Ag Sposób zapobiegania i leczenia nadciśnieniowych chorób serca za pomocą selektywnych estrogenów: 8ß-winylo-estra-1,3,5(10)-trien-3,17ß-diolu i 17ß-fluoro-9a-winylo-estra-1,3,5(10)-trien-3,16a-diolu
DE102004025986A1 (de) 2004-05-21 2005-12-15 Schering Ag Steroid-Prodrugs mit androgener Wirkung
DE102004025966A1 (de) 2004-05-21 2005-12-15 Schering Ag Estradiol-Prodrugs
DE102004025985A1 (de) 2004-05-21 2005-12-15 Schering Ag Estriol- und Estetrol-Prodrugs
US20050277625A1 (en) * 2004-05-21 2005-12-15 Ralf Wyrwa Estriol and estetrol prodrugs
US7534780B2 (en) * 2004-05-21 2009-05-19 Bayer Schering Pharma Aktiengesellschaft Estradiol prodrugs
AR053845A1 (es) 2005-04-15 2007-05-23 Tibotec Pharm Ltd 5-tiazolilmetil[(1s,2r)-3-[[(2-amino-6-benzoxazolil)sulfonil)](2-metilpropil)amino]-2-hidroxi-1-(fenilmetil)propil]carbamato como mejorador de farmacos metabolizados por el citocromo p450

Also Published As

Publication number Publication date
KR20080038460A (ko) 2008-05-06
YU90102A (sh) 2006-05-25
CA2410630A1 (en) 2002-11-28
EA200201201A1 (ru) 2003-06-26
EA006432B1 (ru) 2005-12-29
NZ535201A (en) 2007-01-26
JP2003534386A (ja) 2003-11-18
ATE315407T1 (de) 2006-02-15
CZ2003621A3 (cs) 2003-12-17
PL206462B1 (pl) 2010-08-31
ES2256256T5 (es) 2009-12-11
US20090023896A1 (en) 2009-01-22
PL361426A1 (en) 2004-10-04
MXPA02011844A (es) 2004-05-17
IL152932A0 (en) 2003-06-24
ES2256256T3 (es) 2006-07-16
EP1294402B2 (de) 2009-08-12
WO2001091797A3 (de) 2002-06-20
DE50108674D1 (de) 2006-04-06
HRP20021038B1 (en) 2008-08-31
PT1294402E (pt) 2006-05-31
IL152932A (en) 2007-07-04
EP1294402B1 (de) 2006-01-11
AU2001265933B2 (en) 2007-10-18
SK2912003A3 (en) 2003-09-11
KR20090090398A (ko) 2009-08-25
DK1294402T4 (da) 2009-11-23
US7507725B2 (en) 2009-03-24
BG107556A (bg) 2004-01-30
NO20025739L (no) 2002-11-29
HRP20021038A2 (en) 2004-10-31
NO20025739D0 (no) 2002-11-29
US20040014781A1 (en) 2004-01-22
BR0111294A (pt) 2003-06-10
CN1441678A (zh) 2003-09-10
DK1294402T3 (da) 2006-05-22
HUP0301949A3 (en) 2010-01-28
HUP0301949A2 (hu) 2003-09-29
WO2001091797A2 (de) 2001-12-06
KR20030017524A (ko) 2003-03-03
AU6593301A (en) 2001-12-11
ZA200209490B (en) 2005-03-10
DE10027887A1 (de) 2001-12-13
EP1294402A2 (de) 2003-03-26
UA76953C2 (en) 2006-10-16

Similar Documents

Publication Publication Date Title
MEP14608A (en) Compounds with a sulphonamide group and pharmaceutical compositions containing these compounds
MEP9509A (en) Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
TR200402656T4 (tr) Antikanser ajanları olarak faydalı tiyofen türevleri
MEP36508A (en) Triazolopyrazine derivatives useful as anti-cancer agents
CY1106522T1 (el) Ετepοκυκλικη ενωση και αντικαρκινικο μεσο που πepιεχει την ιδια ως δραστικο συστατικο
ATE234634T1 (de) Feste pharmazeutische formulierungen enthaltend eine physische mischung aus sulphoalkylethercyclodextrin und einem therapeutischen wirkstoff
BRPI0608291A2 (pt) agente imunossupressor e agente antitumoral que compreendem composto heterocìclico como ingrediente ativo
EA199900937A1 (ru) Фармацевтические композиции, содержащие вориконазол
BRPI0518068A (pt) composto ou um éster ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica, inibidor seletivo de aurora a, agente anti-tumor, e, preparação combinada
CO5590918A2 (es) Formulaciones
ES2184293T3 (es) Composiciones farmaceuticas administrables por via oral que comprenden una benzhidrilpiperazina y una ciclodextrina.
ES2174591T3 (es) Composiciones cosmeticas para las axilas con acetato de alquilo inferior.
RS50046B (sr) Farmaceutske kompozicije tizoksanida i nitazoksanida
BR0115454A (pt) Composto de 1-metilcarbapenem ou um sal ou derivado de éster deste farmaceuticamente aceitável, composição farmacêutica, e, uso de um composto ou de um sal ou derivado de éster deste farmaceuticamente aceitável
AR002730A1 (es) Derivados de 4alfa acetiloxi, 2alfa benzoiloxi, epoxi 5 beta, 20 hidroxi-1- beta-metilen-7beta,8beta oxo -9-aciloxi-10beta nor-19-taxen-11-il-13alfa,procedimiento para obtenerlos y composiciones farmaceuticas que incluyen dichos derivados.
AR045912A1 (es) Composiciones farmaceuticas que contienen derivados de azetidina
EA200201024A1 (ru) Фармацевтические композиции, содержащие олигосахариды, и их получение
PA8444901A1 (es) Derivados de 5-aroilnaftaleno como agentes anti-inflamatorios
EA200600022A1 (ru) Применение производных бицикло [2.2.1] гептана для приготовления нейропротекторных фармацевтических композиций
BR0109573A (pt) Composto ou uma pró-droga ou um sal farmacologicamente aceitável do mesmo, agente, composição farmacêutica, e, uso de um composto ou uma pró-droga ou um sal farmacologicamente aceitável do mesmo
FR2797446B1 (fr) Derives de phenanthroline-7-ones et leurs applications en therapeutique
BR9807694A (pt) de um princìpio ativo
BR0215680A (pt) Composição farmacêutica oral estável
EE200100196A (et) a-tsüklodekstriinil põhinevad farmatseutilised kompositsioonid LH-RH analoogide peroraalseks manustamiseks
IL139317A0 (en) Benzimdazole and benzoxazole derivatives and pharmaceutical compositions contining the same